Incyte Corp (INCY)
53.78
+0.69
(+1.30%)
USD |
NASDAQ |
May 03, 16:00
53.78
0.00 (0.00%)
After-Hours: 20:00
Incyte Cash and Short Term Investments (Quarterly): 3.851B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.851B |
| December 31, 2023 | 3.656B |
| September 30, 2023 | 3.516B |
| June 30, 2023 | 3.423B |
| March 31, 2023 | 3.113B |
| December 31, 2022 | 3.239B |
| September 30, 2022 | 2.977B |
| June 30, 2022 | 2.722B |
| March 31, 2022 | 2.544B |
| December 31, 2021 | 2.348B |
| September 30, 2021 | 2.284B |
| June 30, 2021 | 2.081B |
| March 31, 2021 | 1.962B |
| December 31, 2020 | 1.801B |
| September 30, 2020 | 1.735B |
| June 30, 2020 | 1.589B |
| March 31, 2020 | 1.303B |
| December 31, 2019 | 2.118B |
| September 30, 2019 | 1.986B |
| June 30, 2019 | 1.696B |
| March 31, 2019 | 1.581B |
| December 31, 2018 | 1.438B |
| September 30, 2018 | 1.375B |
| June 30, 2018 | 1.198B |
| March 31, 2018 | 1.171B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.170B |
| September 30, 2017 | 1.281B |
| June 30, 2017 | 608.61M |
| March 31, 2017 | 511.96M |
| December 31, 2016 | 808.55M |
| September 30, 2016 | 716.58M |
| June 30, 2016 | 629.19M |
| March 31, 2016 | 810.67M |
| December 31, 2015 | 707.78M |
| September 30, 2015 | 635.04M |
| June 30, 2015 | 627.47M |
| March 31, 2015 | 585.42M |
| December 31, 2014 | 600.26M |
| September 30, 2014 | 532.36M |
| June 30, 2014 | 508.75M |
| March 31, 2014 | 519.23M |
| December 31, 2013 | 509.00M |
| September 30, 2013 | 291.17M |
| June 30, 2013 | 277.45M |
| March 31, 2013 | 270.18M |
| December 31, 2012 | 228.42M |
| September 30, 2012 | 243.60M |
| June 30, 2012 | 261.81M |
| March 31, 2012 | 236.41M |
| December 31, 2011 | 277.59M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.303B
Minimum
Mar 2020
3.851B
Maximum
Mar 2024
2.497B
Average
2.316B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen Inc | 1.074B |
| Novartis AG | 9.694B |
| MorphoSys AG | 754.72M |
| Illumina Inc | 1.054B |
| Pfizer Inc | 12.69B |